Abstract
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 329-331 |
| Number of pages | 3 |
| Journal | Urology |
| Volume | 45 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1995 |
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide'. Together they form a unique fingerprint.
Cite this
Braslis, K. G., David, R. C., Nelson, E., Civantos, F., & Soloway, M. S. (1995). Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. Urology, 45(2), 329-331. https://doi.org/10.1016/0090-4295(95)80028-X